Applied Genomic Technology Capital Funds
3
8M
3
0.14
1
2
- Stages of investment
- Areas of investment
Summary
Applied Genomic Technology Capital Funds appeared to be the VC, which was created in 2000. The leading representative office of defined VC is situated in the Cambridge. The fund was located in North America if to be more exact in United States.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Innovation Management, Medical. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Morphotek.
The increased amount of exits for fund were in 2007. The important activity for fund was in 2001. Deals in the range of 5 - 10 millions dollars are the general things for fund. The typical startup value when the investment from Applied Genomic Technology Capital Funds is 10-50 millions dollars. The fund is constantly included in less than 2 deals per year.
The standard case for the fund is to invest in rounds with 4-5 partakers. The meaningful sponsors for the fund in investment in the same round are Venrock, Turnbridge Capital, Prospect Venture Partners. In the next rounds fund is usually obtained by Rock Maple Ventures, Morgenthaler Ventures, Forward Ventures.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Exits
- 2
- Rounds per year
- 0.14
- Investments by industry
- Medical (3)
- Biotechnology (3)
- Therapeutics (2)
- Pharmaceutical (1)
- Health Care (1) Show 2 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2005
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 3M
- Group Appearance index
- 1.00
- Avg. company exit year
- 7
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Hypnion | 06 Oct 2000 | Biotechnology, Health Diagnostics, Medical, Therapeutics | Early Stage Venture | 10M | United States, Massachusetts |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.